Edmond de Rothschild Holding’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Edmond de Rothschild Holding’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,429	Closed	-$11.6K	–	766
2023 Q1	$11.6K	Hold	1,429	–	–	﹤0.01%	680
2022 Q4	$16.9K	Hold	1,429	–	–	﹤0.01%	724
2022 Q3	$20K	Hold	1,429	–	–	﹤0.01%	744
2022 Q2	$50K	Hold	1,429	–	–	﹤0.01%	662
2022 Q1	$57K	Hold	1,429	–	–	﹤0.01%	662
2021 Q4	$61K	Hold	1,429	–	–	﹤0.01%	686
2021 Q3	$97K	Hold	1,429	–	–	﹤0.01%	635
2021 Q2	$110K	Hold	1,429	–	–	﹤0.01%	601
2021 Q1	$94K	Buy	+1,429	New	+$111K	﹤0.01%	572

Other funds holding DMK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Edmond de Rothschild Holding's DMK Position: Q2 2023 in Review

Edmond de Rothschild Holding sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 1,429 shares — an estimated $11.6K sold.

Edmond de Rothschild Holding first reported a position in DMK in Q1 2021 and held it in 9 quarters. The position peaked at $110K in Q2 2021. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

Edmond de Rothschild Holding reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
Edmond de Rothschild Holding sold 1,429 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $11.6K.
Edmond de Rothschild Holding first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2021 and held it in 9 quarters.
Edmond de Rothschild Holding's DMK Pharmaceuticals Corporation Common Stock position peaked at $110K in Q2 2021.
22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2023, filed 9 Aug 2023.